1.

Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical is...

2.

Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical is...

3.

Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical is...

4.

Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical is...

5.

Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical is...

6.

Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical is...

7.

Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical is...

8.

Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical is...

9.

Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical is...

1.

Variation in antibiotic use in neonatal intensive care units in the Netherlands

2.

Variation in antibiotic use in neonatal intensive care units in the Netherlands

3.

Variation in antibiotic use in neonatal intensive care units in the Netherlands

4.

Variation in antibiotic use in neonatal intensive care units in the Netherlands

5.

Variation in antibiotic use in neonatal intensive care units in the Netherlands

6.

Variation in antibiotic use in neonatal intensive care units in the Netherlands

7.

Variation in antibiotic use in neonatal intensive care units in the Netherlands

8.

Variation in antibiotic use in neonatal intensive care units in the Netherlands

9.

Variation in antibiotic use in neonatal intensive care units in the Netherlands

1.

Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands

2.

Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands

3.

Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands

4.

Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands

5.

Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands

6.

Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands

7.

Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands

8.

Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands

9.

Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands

1.

Intensification of antibiotic use within acute care hospitals in the Netherlands

2.

Intensification of antibiotic use within acute care hospitals in the Netherlands

3.

Intensification of antibiotic use within acute care hospitals in the Netherlands

4.

Intensification of antibiotic use within acute care hospitals in the Netherlands

5.

Intensification of antibiotic use within acute care hospitals in the Netherlands

6.

Intensification of antibiotic use within acute care hospitals in the Netherlands

7.

Intensification of antibiotic use within acute care hospitals in the Netherlands

8.

Intensification of antibiotic use within acute care hospitals in the Netherlands

9.

Intensification of antibiotic use within acute care hospitals in the Netherlands

1.

Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands

2.

Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands

3.

Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands

4.

Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands

1.

Developing quality indicators for general practice care for vulnerable elders; transfer from US to The Netherlands

2.

Developing quality indicators for general practice care for vulnerable elders; transfer from US to The Netherlands

3.

Developing quality indicators for general practice care for vulnerable elders; transfer from US to The Netherlands

4.

Developing quality indicators for general practice care for vulnerable elders; transfer from US to The Netherlands

1.

A core questionnaire for the assessment of patient satisfaction in academic hospitals in The Netherlands: development and first results in a nationwide study

2.

A core questionnaire for the assessment of patient satisfaction in academic hospitals in The Netherlands: development and first results in a nationwide study

3.

A core questionnaire for the assessment of patient satisfaction in academic hospitals in The Netherlands: development and first results in a nationwide study

4.

A core questionnaire for the assessment of patient satisfaction in academic hospitals in The Netherlands: development and first results in a nationwide study

5.

A core questionnaire for the assessment of patient satisfaction in academic hospitals in The Netherlands: development and first results in a nationwide study

6.

A core questionnaire for the assessment of patient satisfaction in academic hospitals in The Netherlands: development and first results in a nationwide study

7.

A core questionnaire for the assessment of patient satisfaction in academic hospitals in The Netherlands: development and first results in a nationwide study

8.

A core questionnaire for the assessment of patient satisfaction in academic hospitals in The Netherlands: development and first results in a nationwide study

9.

A core questionnaire for the assessment of patient satisfaction in academic hospitals in The Netherlands: development and first results in a nationwide study

1.

Quality of after-hours primary care in the Netherlands: adherence to national guidelines

2.

Quality of after-hours primary care in the Netherlands: adherence to national guidelines

3.

Quality of after-hours primary care in the Netherlands: adherence to national guidelines

4.

Quality of after-hours primary care in the Netherlands: adherence to national guidelines

5.

Quality of after-hours primary care in the Netherlands: adherence to national guidelines

6.

Quality of after-hours primary care in the Netherlands: adherence to national guidelines

7.

Quality of after-hours primary care in the Netherlands: adherence to national guidelines

8.

Quality of after-hours primary care in the Netherlands: adherence to national guidelines

9.

Quality of after-hours primary care in the Netherlands: adherence to national guidelines

1.

Trends in Chlamydia trachomatis IgG seroprevalence in the general population of the Netherlands over 20 years

2.

Trends in Chlamydia trachomatis IgG seroprevalence in the general population of the Netherlands over 20 years

3.

Trends in Chlamydia trachomatis IgG seroprevalence in the general population of the Netherlands over 20 years

4.

Trends in Chlamydia trachomatis IgG seroprevalence in the general population of the Netherlands over 20 years

1.

Contribution of sexual health services to hepatitis B detection and control (Netherlands, 2008-2016)

2.

Contribution of sexual health services to hepatitis B detection and control (Netherlands, 2008-2016)

3.

Contribution of sexual health services to hepatitis B detection and control (Netherlands, 2008-2016)

4.

Contribution of sexual health services to hepatitis B detection and control (Netherlands, 2008-2016)